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INCREASE IN PATIENTS ON ART
Background: Engagement and retention in care are main aspects not only for the prognosis of the single patient, but also for the treatment as prevention strategy. American data showed a percentage of engagement in care ranging between 50 and 59%*. This little percentage of subjects engaged in care will result in a lower portion of patients retained in care, since lost at follow up are expected, and consensually less patients with undetectable viral loads. It was also estimated that 80% of in-care HIV positive patients should receive antiretroviral therapy, but a quarter of them is not receiving any treatment. The results is that about only 20% of HIV infected patients, considering both, diagnosed and undiagnosed, had an undetectable plasma HIV-RNA. Aim of our study was to evaluate the engagement and retention in care after diagnosis and the percentage of viral load suppression in an Italian public Health System using data of the Modena HIV Surveillance System. Conclusions: Individuals in care in our center were higher than in USA and this could be probably related either to the two different health systems or to how patients are linked in care. Test and care in Modena were approached in the same clinic and the engagement in care are simultaneous, so the retention in care is very high as the percentage of patients with an undetectable viral load. Secondly, Italian National Health system offers a free of charge: HIV testing, laboratory analyses, hospitalÐ outpatient-home assistance and antiretroviral drugs to all HIV positive subjects independently from their citizenship. Concerning subjects who were lost to follow up, in most cases they move to another Clinical center. This is true especially for foreign people and it is related to occupational problems while IDUs move when they have finished their stay in a local drug rehabilitation center. 
METHODS

RESULTS
Retention in clinical care among men with HIV in the UK Collaborative HIV Cohort (CHIC) Study
BACKGROUND CONCLUSIONS
• Almost 20% of people with HIV in the UK are lost to clinical follow up.
(1) Poor engagement with HIV care is associated with inferior outcomes and increased mortality (2) and undermines the potential for prevention.
• It has been shown that MSM of black ethnicity are more likely to be lost to follow up and 18% less likely to initiate cART than white MSM with similar CD4 counts in the UK. (3) Being female has also been shown to be associated with an increased rate of loss to follow up.
• Although gender and sexual orientation impact on the experience of living with HIV, there are little data comparing HIV-health seeking behaviours of men who identify as heterosexual vs those who identify as homosexual.
• To further investigate the relationships between retention in HIVcare, sexual orientation and ethnicity in men with HIV we present data about men enrolled in the UK CHIC Study.
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• Although these differences are relatively small the reasons behind them merit further exploration to secure equitable outcomes for all men with HIV in the UK
• Limitations of this study are those inherent to all observational data sets in that they do not provide an explanation as to why the differences occur. Patients may transfer to non-UK CHIC centres and hence appear as not being engaged in care. Additionally country of birth is not captured in the UK CHIC study.
Consistent retention in care
• 
DEFINITIONS
Initial engagement in care: defined as having ever had >1 day of follow up in a UK CHIC centre.
Consistent retention in care:
defined as having had no interval between consecutive CD4 cell count or viral load measurements of more than 6 months during follow-up. 
Initial engagement in care
• 32045 (96.5%) men were initially engaged in care (figures 1-3).
• Being MSM, older age, being on cART and having AIDS at entry (see table 2 ) were all associated with initial engagement
• Ethnicity was not associated with initial engagement in care. 
INTRODUCTION

Poor Fup/Adh was associated with virologic failure leading to an increase in mortality and resource use. (1,2) .  SEAD was a multidimensional intervention project, designed from the patient's perspective, to specifically attend patients with poor FUP/ ADH in an HIV/AIDS outpatient clinic.
OBJECTIVE
Evaluate the effect of different interventions on survival of patients admitted to the SEAD project.
METHODS. 
In the SEAD project, all patients were evaluated by a nurse or a psychologist (adherence collaborators) who assessed all the reasons and barriers precluding a correct FUP/ADH. For each identified problem, different interventions were planned, using our own resources or coordinating others. Estimative Cox regression models were created to evaluate the different interventions, adjusting by the significant variables identified in the predictive model. 
RESULTS
Deaths
Deaths* (between baseline and M12) 6
Raltegravir-related deaths 0
Background and objectives
Clinical trials have shown that Raltegravir is an effective anti-retroviral compound with a good safety profile.
In order to assess the use of Raltegravir in routine practice, a large observational French cohort, RACING, has been set up to study treatment efficacy, safety, patient adherence and quality of life in a "real-life" setting.
This poster presents data which focuses on patientsʼ characteristics and their assessment over a 12-month period. This observational study, RACING, is based on data declared by physicians.
Methods
Standardized monitoring was proposed but not imposed, keeping in-line with French experts recommendations for care of HIV-infected patients.
In terms of safety, the results from this 12-month analysis, concerning Raltegravir, are good.
There was a significant improvement in the quality of life of patients receiving Raltegravir treatment despite the strong presence of co-morbidity.
The efficacy data, observed after 12 months of Raltegravir use in a ʻreal-lifeʼ setting, are comparable to the data already observed in clinical trials. These results must be confirmed at M18 and M24. 
Introduction
Chelsea and Westminster Hospital NHS Foundation Trust and its off-site clinics collectively make up one of the largest HIV units in Europe and is internationally renowned as a centre of excellence in the care of HIV. The Clinic at 56 Dean Street, Soho is one of the fastest growing sexual health clinics in London, providing a comprehensive range of sexual health and HIV services in an integrated outpatient setting. Pharmacy services were extended at this clinic at the beginning of 2012 to accommodate the growth in patient numbers by introduction of a full-time satellite dispensary service. The aim of this study was to evaluate the impact of this restructured pharmacy service on patient satisfaction and efficiency of the pharmacy service.
Method
Pharmacy services were evaluated across a range of pharmaceutical parameters over a one week period pre-restructure and then re-evaluated for another 1 week period 2 months post restructure. Dispensing times were recorded using specific time audit slips, pharmacist interventions including the time taken per intervention and repeat prescription requests were recorded on logs. A pharmacy service questionnaire was designed to assess patient satisfaction using a visual analogue scale and six statements. Responses were evaluated using a five point Likert type scale of agreement/disagreement (strongly agree, agree, uncertain, disagree and strongly disagree). The data collected was then tabulated and statistical tests were carried out using SPSS software. Table 2 : Change in patient satisfaction pre (n=21) and post (n=51) restructure of services using the Mann -Whitney U Test
Results
PATIENT SATISFACTION
